Letermovir was shown to be just as effective as valganciclovir in preventing CMV in kidney transplant recipients in new study published in JAMA; results prompt additional FDA approval for this indication.
Researchers have developed and validated a new race-free, creatinine-based equation for estimating glomerular filtration rate specifically designed for kidney transplant recipients.
Early concerns of disease transmission slowed the use of kidneys from donors with resolved or active COVID-19; however, use has increased with evidence of safety.
User-friendly ChatGPT-like system allows for accurate diagnoses of rejection, using often complicated Banff classification criteria with just a few clicks. Observers hail the work as innovative.
Screening for coronary heart disease in asymptomatic, low-risk people listed for a kidney transplant often happens in US practice, but evidence showing it helps is lacking.